1.
Braz. j. infect. dis
;
14(5): 513-518, Sept.-Oct. 2010. ilus
Artículo
en Inglés
| LILACS
| ID: lil-570569
RESUMEN
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection.